Effect of Xinyue capsules on patients with coronary heart disease after percutaneous coronary intervention: study protocol for a randomized controlled trial

BACKGROUND: The risk of cardiovascular events remains high in patients with coronary heart disease (CHD) after successful percutaneous coronary intervention (PCI). Panax quinquefolius saponin, a major component of Xinyue capsule, has been used to treat patients with CHD. The aim of this study is to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Trials
Hauptverfasser: Guo, Ming, Zi, Ming-jie, Xi, Rui-xi, Yang, Qiao-ning, Bai, Rui-na, Zhang, Yi-sheng, Wang, Yu-hua, Wang, Pei-li, Shi, Da-zhuo
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2016
Schlagworte:
Study Protocol
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4991005/
https://ncbi.nlm.nih.gov/pubmed/27538952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-016-1531-x
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge